Synthaverse S.A. (WSE:SVE)
2.750
+0.030 (1.10%)
Jun 12, 2026, 5:00 PM CET
Synthaverse Revenue
Synthaverse had revenue of 13.61M PLN in the quarter ending March 31, 2026, with 1.35% growth. This brings the company's revenue in the last twelve months to 42.19M, down -40.81% year-over-year. In the year 2025, Synthaverse had annual revenue of 42.01M, down -41.46%.
Revenue (ttm)
42.19M
Revenue Growth
-40.81%
P/S Ratio
4.94
Revenue / Employee
197.15K
Employees
214
Market Cap
208.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.01M | -29.75M | -41.46% |
| Dec 31, 2024 | 71.76M | 13.15M | 22.44% |
| Dec 31, 2023 | 58.61M | 8.22M | 16.32% |
| Dec 31, 2022 | 50.38M | 9.23M | 22.43% |
| Dec 31, 2021 | 41.15M | 995.00K | 2.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 266.02M |
| Ryvu Therapeutics | 88.38M |
| Mabion | 17.61M |
| Molecure | 6.52M |
| Urteste | 2.50M |
| Captor Therapeutics Spolka Akcyjna | 2.38M |
| Pharmena | 1.61M |
| Poltreg | 250.00K |